Tezepelumab

Tezspire 210 MG Solucion Inyectable en Pluma Precargada

210 mg solución inyectable en pluma precargadaSpainMarketedAuthorised 8 Mar 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TezspireEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tezepelumab

Tezspire 210 MG Solucion Inyectable en Pluma Precargada

210 mg solución inyectable en pluma precargadaSpainMarketedAuthorised 8 Mar 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

TezspireEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tezspire, 110 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · AstraZeneca AB

Tezspire®Serbia · 210mg · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Astrazeneca UK Limited Beograd

Tezspire®Serbia · 210mg · rastvor za injekciju u napunjenom injekcionom penu · PredstavniŠTvo Astrazeneca UK Limited Beograd

Tezspire 210 mg per 1.9 mlSaudi Arabia · Amgen Manufacturing Limited

Tezspire Solution for Injection 210 MG in Pre-Filled PenSingapore · 210 mg/unit · injection, solution · Astrazeneca Singapore Pte LTD

Tezspire Solution for Injection 210 MG in Pre-Filled SyringeSingapore · 210 mg/unit · injection, solution · Astrazeneca Singapore Pte LTD

TezspireUnited States · 210MG/1.91ML · Injection · AstraZeneca AB

TezspireUnited States · 210MG/1.91ML · solution · Astrazeneca AB

Packs

Pack	Code	Status
TEZSPIRE 210 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada	762356

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tezepelumab
Strength: 210 mg
Dosage form: solución inyectable en pluma precargada
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 8 Mar 2023
Registration: 1221677003
Marketing authorisation holder: Astrazeneca Ab
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/22/1677